Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Leonard Chapman
CEOStephen Leonard Chapman
Employees
4,434
Employees4,434
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
4,434
Employees4,434

NTRA Key Statistics

Market cap
28.44B
Market cap28.44B
Price-Earnings ratio
-89.43
Price-Earnings ratio-89.43
Dividend yield
Dividend yield
Average volume
1.64M
Average volume1.64M
High today
$208.54
High today$208.54
Low today
$203.00
Low today$203.00
Open price
$204.28
Open price$204.28
Volume
1.05M
Volume1.05M
52 Week high
$212.21
52 Week high$212.21
52 Week low
$125.38
52 Week low$125.38

Stock Snapshot

The current Natera(NTRA) stock price is $206.04, with a market capitalization of 28.44B. The stock trades at a price-to-earnings (P/E) ratio of -89.43.

On 2025-11-17, Natera(NTRA) stock traded between a low of $203.00 and a high of $208.54. Shares are currently priced at $206.04, which is +1.5% above the low and -1.2% below the high.

Natera(NTRA) shares are trading with a volume of 1.05M, against a daily average of 1.64M.

During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $212.21 at its peak.

During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $212.21 at its peak.

NTRA News

TipRanks 4d
Natera price target raised to $235 from $197 at Stephens

Stephens raised the firm’s price target on Natera (NTRA) to $235 from $197 and keeps an Overweight rating on the shares after the company reported “another stro...

Simply Wall St 5d
Stocks That May Be Priced Below Intrinsic Value In November 2025

As the U.S. market experiences mixed outcomes with the Dow Jones Industrial Average reaching unprecedented heights and the Nasdaq showing signs of volatility, i...

Stocks That May Be Priced Below Intrinsic Value In November 2025
Simply Wall St 6d
Natera Is Up 5.2% After Raising 2025 Revenue Guidance and Expanding Women’s Health Portfolio

Natera announced strong third quarter results and raised its 2025 revenue guidance by US$160 million, now expecting between US$2.18 billion and US$2.26 billion,...

Natera Is Up 5.2% After Raising 2025 Revenue Guidance and Expanding Women’s Health Portfolio

Analyst ratings

90%

of 21 ratings
Buy
90.5%
Hold
9.5%
Sell
0%

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.